These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 33177389

  • 1. Targeting neuropilin-1 interactions is a promising anti-tumor strategy.
    Liu SD, Zhong LP, He J, Zhao YX.
    Chin Med J (Engl); 2020 Nov 09; 134(5):508-517. PubMed ID: 33177389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
    Kawakami T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Abe Y, Osamura Y, Inoue H, Ueyama Y, Nakamura M.
    Cancer; 2002 Nov 15; 95(10):2196-201. PubMed ID: 12412174
    [Abstract] [Full Text] [Related]

  • 5. New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies.
    Zhao L, Chen H, Lu L, Wang L, Zhang X, Guo X.
    J Drug Target; 2021 Feb 15; 29(2):155-167. PubMed ID: 32838575
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Hong TM, Chen YL, Wu YY, Yuan A, Chao YC, Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, Chan WK, Yang PC.
    Clin Cancer Res; 2007 Aug 15; 13(16):4759-68. PubMed ID: 17699853
    [Abstract] [Full Text] [Related]

  • 8. Neuropilin 1: function and therapeutic potential in cancer.
    Chaudhary B, Khaled YS, Ammori BJ, Elkord E.
    Cancer Immunol Immunother; 2014 Feb 15; 63(2):81-99. PubMed ID: 24263240
    [Abstract] [Full Text] [Related]

  • 9. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.
    Quante M, Raskopf E, Stahl S, Vogt A, Sauerbruch T, Schmitz V.
    Oncol Rep; 2009 May 15; 21(5):1161-8. PubMed ID: 19360289
    [Abstract] [Full Text] [Related]

  • 10. The role of neuropilin in vascular and tumor biology.
    Klagsbrun M, Takashima S, Mamluk R.
    Adv Exp Med Biol; 2002 May 15; 515():33-48. PubMed ID: 12613541
    [Abstract] [Full Text] [Related]

  • 11. Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis.
    Raimondi C.
    Biochem Soc Trans; 2014 Oct 15; 42(5):1429-34. PubMed ID: 25233427
    [Abstract] [Full Text] [Related]

  • 12. Neuropilins in neoplasms: expression, regulation, and function.
    Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M.
    Exp Cell Res; 2006 Mar 10; 312(5):584-93. PubMed ID: 16445911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
    Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M.
    FASEB J; 2000 Dec 10; 14(15):2532-9. PubMed ID: 11099472
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
    Kim YJ, Bae J, Shin TH, Kang SH, Jeong M, Han Y, Park JH, Kim SK, Kim YS.
    J Control Release; 2015 Oct 28; 216():56-68. PubMed ID: 26260451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma.
    Morin E, Lindskog C, Johansson M, Egevad L, Sandström P, Harmenberg U, Claesson-Welsh L, Sjöberg E.
    J Pathol; 2020 Apr 28; 250(4):387-396. PubMed ID: 31880322
    [Abstract] [Full Text] [Related]

  • 20. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.
    Saban MR, Sferra TJ, Davis CA, Simpson C, Allen A, Maier J, Fowler B, Knowlton N, Birder L, Wu XR, Saban R.
    Am J Physiol Renal Physiol; 2010 Dec 28; 299(6):F1245-56. PubMed ID: 20861073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.